UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

JAMA : the journal of the American Medical Association, 1999-11, Vol.282 (20), p.1921

1999

Volltextzugriff (PDF)

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis : randomised double-blind comparison

The Lancet (British edition), 1999-12, Vol.354 (9196), p.2106-2111

1999

Volltextzugriff (PDF)

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

The American journal of gastroenterology, 2000-07, Vol.95 (7), p.1681-1690

2000

Volltextzugriff (PDF)

Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen

Kidney international, 2006-10, Vol.70 (8), p.1495-1502

2006

Volltextzugriff (PDF)

Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial

Mayo Clinic proceedings, 1999-11, Vol.74 (11), p.1095-1105

1999

Volltextzugriff (PDF)

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

The American journal of gastroenterology, 2001-04, Vol.96 (4), p.1019-1027

2001

Volltextzugriff (PDF)

Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial

British journal of rheumatology, 2003-10, Vol.42 (10), p.1207-1215

2003

Volltextzugriff (PDF)

Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery

The New England journal of medicine, 2005-03, Vol.352 (11), p.1081-1091

2005

Volltextzugriff (PDF)

Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients

Osteoarthritis and cartilage, 2019-03, Vol.27 (3), p.484-492

2019

Volltextzugriff (PDF)

Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients

Osteoarthritis and cartilage, 2017-06, Vol.25 (6), p.866-877

2017

Volltextzugriff (PDF)

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

American journal of therapeutics, 2000-05, Vol.7 (3), p.159-174

2000

Volltextzugriff (PDF)

Reduced incidence of upper gastrointestinal ulcer complications with the COX‐2 selective inhibitor, valdecoxib

Alimentary pharmacology & therapeutics, 2004-09, Vol.20 (5), p.527-538

2004

Volltextzugriff (PDF)

A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (1), p.125-132

2003

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip

Journal of international medical research, 2001-12, Vol.29 (6), p.467-479

2001

Volltextzugriff (PDF)

Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults

Clinical therapeutics, 2001-02, Vol.23 (2), p.228-241

2001

Volltextzugriff (PDF)

Effects of celecoxib and naproxen on renal function in the elderly

Archives of internal medicine (1960), 2000-05, Vol.160 (10), p.1465

2000

Volltextzugriff (PDF)

Increased Capillary Hydraulic Conductivity Induced by Atrial Natriuretic Peptide

Circulation research, 1987-02, Vol.60 (2), p.304-307

1987

Volltextzugriff (PDF)

A Single Preoperative Oral Dose of Valdecoxib, a New Cyclooxygenase-2 Specific Inhibitor, Relieves Post-Oral Surgery or Bunionectomy Pain

Anesthesiology (Philadelphia), 2002-09, Vol.97 (3), p.565-573

2002

Volltextzugriff (PDF)

Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen

Journal of rheumatology, 2014-11, Vol.41 (11), p.2249-2259

2014

Volltextzugriff (PDF)

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

Pain (Amsterdam), 2013-07, Vol.154 (7), p.1009-1021

2013

Volltextzugriff (PDF)

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1202-1211

2015

Volltextzugriff (PDF)

Efficacy and safety of tanezumab in the treatment of pain from bone metastases

Pain (Amsterdam), 2015-09, Vol.156 (9), p.1703-1713

2015

Volltextzugriff (PDF)

Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis

Journal of rheumatology, 2004-08, Vol.31 (8), p.1614

2004

Volltextzugriff (PDF)

Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea

Obstetrics and gynecology (New York. 1953), 2002-08, Vol.100 (2), p.350-358

2002

Volltextzugriff (PDF)

The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, Opioid-Sparing Analgesic in Patients Undergoing Total Knee Arthroplasty

Journal of pain and symptom management, 2003-02, Vol.25 (2), p.133-141

2003

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(147)
Humans
(104)
Biological And Medical Sciences
(88)
Male
(87)
Female
(84)
Medical Sciences
(62)
Middle Aged
(57)
Adult
(48)
Aged
(44)
Animals
(38)
Fundamental And Applied Biological Sciences. Psychology
(30)
Double-Blind Method
(29)
Pharmacology. Drug Treatments
(28)
Sulfonamides - Adverse Effects
(22)
Treatment Outcome
(21)
Cyclooxygenase Inhibitors - Adverse Effects
(20)
Rheumatology
(20)
Anti-Inflammatory Agents, Non-Steroidal - Adverse Effects
(19)
Pharmacology & Pharmacy
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis : randomised double-blind comparison

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen

Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial

Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery

Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients

Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

Reduced incidence of upper gastrointestinal ulcer complications with the COX‐2 selective inhibitor, valdecoxib

A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects

Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip

Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults

Effects of celecoxib and naproxen on renal function in the elderly

Increased Capillary Hydraulic Conductivity Induced by Atrial Natriuretic Peptide

A Single Preoperative Oral Dose of Valdecoxib, a New Cyclooxygenase-2 Specific Inhibitor, Relieves Post-Oral Surgery or Bunionectomy Pain

Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain

Efficacy and safety of tanezumab in the treatment of pain from bone metastases

Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis

Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea

The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, Opioid-Sparing Analgesic in Patients Undergoing Total Knee Arthroplasty

Suchergebnisse filtern